137 related articles for article (PubMed ID: 26944187)
1. Self-reported human papillomavirus vaccination does not have an impact on the risk for high-grade cervical intraepithelial neoplasia among women referred for colposcopy.
Kuroki LM; Binder PS; Powell MA; Massad LS; Gao F
Am J Obstet Gynecol; 2016 Jul; 215(1):123-6. PubMed ID: 26944187
[No Abstract] [Full Text] [Related]
2. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
[TBL] [Abstract][Full Text] [Related]
3. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.
Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Cotton S; Nicoll S; Robertson C
Br J Cancer; 2016 Mar; 114(5):582-9. PubMed ID: 26931370
[TBL] [Abstract][Full Text] [Related]
4. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
Adam E; Kaufman RH; Berkova Z; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1998 Jun; 178(6):1235-44. PubMed ID: 9662307
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
Dempster-Rivett K; Innes CR; Simcock BJ; Harker D; Williman JA; Van Der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Pather S; Wrede CD; Sykes PH
Am J Obstet Gynecol; 2020 Sep; 223(3):408.e1-408.e11. PubMed ID: 32109465
[TBL] [Abstract][Full Text] [Related]
7. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.
Hildesheim A; Gonzalez P; Kreimer AR; Wacholder S; Schussler J; Rodriguez AC; Porras C; Schiffman M; Sidawy M; Schiller JT; Lowy DR; Herrero R;
Am J Obstet Gynecol; 2016 Aug; 215(2):212.e1-212.e15. PubMed ID: 26892991
[TBL] [Abstract][Full Text] [Related]
8. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
[TBL] [Abstract][Full Text] [Related]
10. The impact of the distribution of human papillomavirus types and associated high-risk lesions in a colposcopy population for monitoring vaccine efficacy.
Antonishyn NA; Horsman GB; Kelln RA; Saggar J; Severini A
Arch Pathol Lab Med; 2008 Jan; 132(1):54-60. PubMed ID: 18181674
[TBL] [Abstract][Full Text] [Related]
11. The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.
Munro A; Gillespie C; Cotton S; Busby-Earle C; Kavanagh K; Cuschieri K; Cubie H; Robertson C; Smart L; Pollock K; Moore C; Palmer T; Cruickshank ME
BJOG; 2017 Aug; 124(9):1394-1401. PubMed ID: 28102931
[TBL] [Abstract][Full Text] [Related]
12. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
13. Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland.
Pollock KG; Kavanagh K; Potts A; Love J; Cuschieri K; Cubie H; Robertson C; Cruickshank M; Palmer TJ; Nicoll S; Donaghy M
Br J Cancer; 2014 Oct; 111(9):1824-30. PubMed ID: 25180766
[TBL] [Abstract][Full Text] [Related]
14. Outcome of Nonpersonalized Human Papillomavirus Vaccinations During Postconization Follow-up: A Report of Two Cases.
Giannella L; Mfuta K; Fodero C; Prandi S
J Reprod Med; 2015; 60(9-10):455-7. PubMed ID: 26592077
[TBL] [Abstract][Full Text] [Related]
15. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
16. Treatment of women with low-grade squamous intraepithelial lesions on cytologic evidence or biopsy results by board-certified gynecologists.
Lee C; Mancuso V; Contant T; Jackson R; Smith-Mccune K
Am J Obstet Gynecol; 2003 Mar; 188(3):693-8. PubMed ID: 12634642
[TBL] [Abstract][Full Text] [Related]
17. Anticipating the Impact of Human Papillomavirus Vaccination on US Cervical Cancer Prevention Strategies.
Massad LS
J Low Genit Tract Dis; 2018 Apr; 22(2):123-125. PubMed ID: 29474243
[TBL] [Abstract][Full Text] [Related]
18. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study.
Margolis KL; Carson LF; Setness PA; Stanley MW; Henry-Stanley MJ; Beneke J; Linzie B; McGlennen RC
Arch Fam Med; 1999; 8(5):433-9. PubMed ID: 10500518
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia.
Petry KU; Böhmer G; Iftner T; Davies P; Brummer O; Kühnle H
Am J Obstet Gynecol; 2002 Jan; 186(1):28-34. PubMed ID: 11810080
[TBL] [Abstract][Full Text] [Related]
20. Colposcopic performance in a birth cohort previously eligible for human papillomavirus vaccination.
Sahlgren HAI; Elfgren K; Sparen P; Elfstrom MK
Am J Obstet Gynecol; 2022 May; 226(5):704.e1-704.e9. PubMed ID: 34954217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
